Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
Several borrowers have entered the Schuldschein market after car parts maker Robert Bosch fired the starting gun on the market's reopening last week. Market participants are now eager to know which will be the first non-German issuer. -
Harley-Davidson, the US motorbike maker, has opened books on a three year euro bond at a nosebleed-inducing wide spread. Bankers suggest the company had little choice but to accept to pay a sky high margin.
-
Covid-19 has fundamentally altered the way people work, communicate and live. It has also tested the resilience of Asia’s capital markets, writes Matthew Thomas.
-
India is facing yet another upheaval as the Covid-19 pandemic makes its way through the country. Capital markets activity has all but come to a halt. There are few bright spots, but bankers are focusing on innovation and thinking long term. By Rashmi Kumar
-
The Covid-19 pandemic has forced Asia’s debt issuers to confront a fundamental question: how can they raise money in these turbulent times? Bond bankers are scrambling to find the best solutions for their clients as they position themselves for when the market reopens. Morgan Davis reports.
-
It should come as little surprise that the Covid-19 pandemic has led to a sharp repricing of Chinese bonds in the onshore and offshore markets. What might be a surprise is that the two markets have gone in different directions. Rebecca Feng reports
